SLIDE 1
1
Paper Presentation Guidelines
IMAGING IN THE EYE CONFERENCE REGISTRATION All presenters must register and pay the fees to attend the Imaging in the Eye Conference. (ARVO Annual Meeting registration is separate). Register online. Early registration discounts end on Friday, March 22. Presenters are strongly encouraged to register/print their meeting badges on Friday, April 26, 2019. Badge Printing Kiosks will be available onsite, Friday, April 26, between 4:00 – 9:00 PM at the Vancouver Convention Centre (East), Convention Level - Ballrooms A, B, and C. PRESENTATION CONTENT Saturday, April 27, 8:00 AM – 5:30 PM Abstract Presentations in Paper Sessions: Scheduled in 15-minute blocks for each abstract – 10 minutes for the presentation, and 5 minutes for discussion. Abstract presentations may not exceed the 15-minute time block. The abstract’s First Author must present the same work described in the abstract, with the same title and content, and will reveal the essential structures (DNA sequences, molecules, etc.), the elements of a novel compound, and sufficient identification of new gene compounds as part of their presentation. ABSTRACT WITHDRAWAL POLICY As the abstract’s First Author, you are obligated to present your abstract. Changes to the presentation type, session and time cannot be made; no exceptions.
- If you are unable to attend and present your abstract, you must follow the ARVO Imaging in the Eye
Abstract Withdrawal Policy located on the Imaging Conference Abstracts page under “Reference Tools.”
- A co-author who is not pre-approved by Meeting Management as a Substitute Presenter or any other
colleague who is not a co-author on the abstract will not be allowed to present the abstract on your behalf. DISCLOSURES
- First/Presenting Authors must fully disclose to ARVO and the session participants all commercial
relationships relevant to the subject matter for the prior 12 months for themselves, their spouse/partner and all co-authors of the presentation.
- Full disclosure will include the name(s) of the commercial interest and the nature of the relationship(s).
“None” must be indicated if no relationships exist.
- All full disclosures must be indicated orally and on a Presenter Disclosure Slide at the beginning of your
presentation.
- Moderators will be onsite to ensure compliance with these requirements.
- View the ARVO Commercial Relationships Policy for complete reporting requirements and Disclosure